Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance

Journal of Cell Biology

Volumn 146, Issue 4, 1999, Pages 893-904

  Tachibana, Isao ^a,b   Hemler, Martin E ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

CD81; CD9; Myoblast; Myotube; TM4SF proteins

Indexed keywords

CD81 ANTIGEN; CD9 ANTIGEN; INTEGRIN; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; ARTICLE; CELL FUSION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD29; APOPTOSIS; CELL DIFFERENTIATION; CELL FUSION; CELL LINE; DESMIN; DNA FRAGMENTATION; GENE EXPRESSION REGULATION; GIANT CELLS; HISTOCOMPATIBILITY ANTIGENS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MUSCLE, SKELETAL; PRECIPITIN TESTS; TIME FACTORS; TUMOR CELLS, CULTURED;

MURINAE;

EID: 0033598128     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.146.4.893     Document Type: Article

References (80)

1. Angelisova, P., I. Hilgerl, and V. Horejsi. 1994. Association of four antigens of the tetraspan family (CD37, CD53, TAPA-1 and R2/C33) with MHC class II glycoproteins. Immunogenetics. 39:249-256.
2. Anton, E.S., M. Hadjiargyrou, P.H. Patterson, and W.D. Matthew. 1995. CD9 plays a role in Schwann cell migration in vitro. J. Neurosci. 15:584-595.
3. Deleted in proof.
4. Bao, Z.Z., M. Lakonishok, S. Kaufman, and A.F. Horwitz. 1993. α7β1 integrin is a component of the myotendinous junction of skeletal muscle. J. Cell Sci. 106:579-590.
5. Belkin, A.M., N.I. Zhidkova, F. Balzac, F. Altruda, D. Tomatis, A. Maier, G. Tarone, V.E. Koteliansky, and K. Burridge. 1996. Beta 1D integrin displaces the beta 1A isoform in striated muscles: localization at junctional structures and signaling potential in nonmuscle cells. J. Cell Biol. 132:211-226.
6. Berditchevski, F., M.M. Zutter, and M.E. Hemler. 1996. Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol. Biol. Cell. 7:193-207.
7. Berditchevski, F., K.F. Tolias, K. Wong, C.L. Carpenter, and M.E. Hemler. 1997. A novel link between integrins, TM4SF proteins (CD63, CD81) and phosphatidylinositol 4-kinase. J. Biol. Chem. 272:2595-2598.
8. Blau, H.M., G.K. Pavlath, B.C. Hardeman, C.P. Chiu, L. Silberstein, S.G. Webster, S.C. Miller, and C. Webster. 1985. Plasticity of the differentiated state. Science. 230:758-766.
9. Boesze-Battaglia, K., F. Kong, O.P. Lamba, F.P. Stefano, and D.S. Williams. 1997. Purification and light-dependent phosphorylation of a candidate fusion protein, the photoreceptor cell peripherin/rds. Biochemistry. 36:6835-6846.
10. Boismenu, R., M. Rhein, W.H. Fischer, and W.L. Havran. 1996. A role for CD81 in early T cell development. Science. 271:198-200.
11. Bouché, M., M.I. Senni, A.M. Grossi, F. Zappelli, M. Polimeni, H.H. Arnold, G. Cossu, and M. Molinaro. 1993. TPA-induced differentiation of human rhabdomyosarcoma cells: expression of the myogenic regulatory factors. Exp. Cell Res. 208:209-217.
12. Carmo, A.M., and M.D. Wright. 1995. Association of the transmembrane 4 superfamily molecule CD53 with a tyrosine phosphatase activity. Eur. J. Immunol. 25:2090-2095.
13. Charlton, C.A., W.A. Mohler, G.L. Radice, R.O. Hynes, and H.M. Blau. 1997. Fusion competence of myoblasts rendered genetically null for N-cadherin in culture. J. Cell Biol. 138:331-336.
14. Collo, G., L. Starr, and V. Quaranta. 1993. A new isoform of the laminin receptor integrin α7β1 is developmentally regulated in skeletal muscle. J. Biol. Chem. 268:19019-19024.
15. Crawley, S., E.M. Farrell, W. Wang, M. Gu, H.Y. Huang, Y. Huynh, B.L. Hodges, D.N. Cooper, and S.J. Kaufman. 1997. The α7β1 integrin mediates adhesion and migration of skeletal myoblasts on laminin. Exp. Cell Res. 235:274-286.
16. David, J.D., C.R. Faser, and G.P. Perrot. 1990. Role of protein kinase C in chick embryo skeletal myoblast fusion. Dev. Biol. 139:89-99.
17. de Parseval, A., D.L. Lerner, P. Borrow, B. Willett, and J.H. Elder. 1997. Blocking of feline immunodeficiency virus infection by a monoclonal antibody to CD9 is via inhibition of virus release rather than interference with receptor binding. J. Virol. 71:5742-5749.
18. Dickson, G., D. Peck, S.E. Moore, C.H. Barton, and F.S. Walsh. 1990. Enhanced myogenesis in NCAM-transfected mouse myoblasts. Nature. 344: 348-351.
19. Ferguson, T.A., and T.S. Kupper. 1993. Antigen-independent processes in antigen-specific immunity. A role for alpha 4 integrin. J. Immunol. 150: 1172-1182.
20. Fukudome, K., M. Furuse, T. Imai, M. Nishimura, S. Takagi, Y. Hinuma, and O. Yoshie. 1992. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells. J. Virol. 66:1394-1401.
21. Gavrieli, Y., Y. Sherman, and S.A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
22. Hadjiargyrou, M., Z. Kaprielian, N. Kato, and P.H. Patterson. 1996. Association of the tetraspan protein CD9 with integrins on the surface of S-16 Schwann cells. J. Neurochem. 67:2505-2513.
23. Halvorson, M.J., and J.E. Coligan. 1995. Enhancement of VLA integrin receptor function on thymocytes by cAMP is dependent on the maturation stage of the thymocytes. J. Immunol. 155:4567-4574.
24. Hemler, M.E. 1998. Integrin-associated proteins. Curr. Opin. Cell Biol. 10: 578-585.
25. Deleted in proof.
26. Hemler, M.E., B.A. Mannion, and F. Berditchevski. 1996. Association of TM4SF proteins with integrins: relevance to cancer. Biochim. Biophys. Acta. 1287:67-71.
27. Hirsch, E., L. Lohikangas, D. Gullberg, S. Johansson, and R. Fassler. 1998. Mouse myoblasts can fuse and form a normal sarcomere in the absence of β1 integrin expression. J. Cell Sci. 111:2397-2409.
28. Hiti, A., E. Bogenmann, F. Gonzales, and P.A. Jones. 1989. Expression of the MyoD1 muscle determination gene defines differentiation capability but not tumorigenicity of human rhabdomyosarcomas. Mol. Cell. Biol. 9:4722-4730.
29. Hong, D.H., J. Huan, B.R. Ou, J.Y. Yeh, T.C Saido, P.R. Cheeke, and N.E. Forsberg. 1995. Protein kinase C isoforms in muscle cells and their regulation by phorbol ester and calpain. Biochim. Biophys. Acta. 1267: 45-54.
30. Horejsí, V., and C. Vlcek. 1991. Novel structurally distinct family of leucocyte surface glycoproteins including CD9, CD37, CD53 and CD63. FEBS Lett. 288:1-4.
31. Ikeyama, S., M. Koyama, M. Yamaoko, R. Sasada, and M. Miyake. 1993. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J. Exp. Med. 177:1231-1237.
32. 31a. Imai, T., K. Fukudome, S. Takagi, M. Nagira, M. Furuse, N. Fukuhara, M. Nishimura, Y. Hinuma, and O. Yoshie. 1992. C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63. J. Immunol. 149:2879-2886.
33. Jaffredo, T., A.F. Horwitz, C.A. Buck, P.M. Rong, and F. Dieterlen-Lievre. 1988. Myoblast migration specifically inhibited in the chick embryo by grafted CSAT hybridoma cells secreting an anti-integrin antibody. Development. 103:431-446.
34. Jones, P.H., L.A. Bishop, and F.M. Watt. 1996. Functional significance of CD9 association with β1 integrins in human epidermal keratinocytes. Cell Adhes. Commun. 4:297-305.
35. Kang, J.-S., P.J. Mulieri, C. Miller, D.A. Sassoon, and R.S. Krauss. 1998. CDO, a robo-related cell surface protein that mediates myogenic differentiation. J. Cell Biol. 143:403-413.
36. Knudsen, K.A., S.A. McElwee, and L. Myers. 1990. A role for the neural cell adhesion molecule, NCAM, in myoblast interaction during myogenesis. Dev. Biol. 138:159-168.
37. Knudsen, K.A., L. Myers, and S.A. McElwee. 1990. A role for the Ca2(+)-dependent adhesion molecule, N-cadherin, in myoblast interaction during myogenesis. Exp. Cell Res. 188:175-184.
38. Lakonishok, M., J. Muschler, and A.F. Horwitz. 1992. The α5β1 integrin associates with a dystrophin-containing lattice during muscle development. Dev. Biol. 152:209-220.
39. Lassar, A.B., S.X. Skapek, and B. Novitch. 1994. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6:788-794.
40. Löffler, S., F. Lottspeich, F. Lanza, D.O. Azorsa, V. Meulen, and J. Schneider-Schaulies. 1997. CD9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus. J. Virol. 71:42-49.
41. Maecker, H.T., S.C. Todd, and S. Levy. 1997. The tetraspanin superfamily: molecular facilitators. FASEB J. 11:428-442.
42. Mannion, B.A., F. Berditchevski, S.-K. Kraeft, L.B. Chen, and M.E. Hemler. 1996. TM4SF proteins CD81 (TAPA-1), CD82, CD63 and CD53 specifically associate with α4β1 integrin. J. Immunol. 157:2039-2047.
43. Mayer, U., G. Saher, R. Fässler, A. Bornemann, R. Echtermeyer, K. Von der Mark, N. Miosge, and E. Poeschi. 1997. Absence of integrin α7 causes a novel form of muscular dystrophy. Nat. Genet. 17:318-323.
44. McDonald, K.A., M. Lakonishok, and A.F. Horwitz. 1995. αV and α3 integrin subunits are associated with myofibrils during myofibrillogenesis. J. Cell Sci. 108:975-983.
45. Mechtersheimer, G., T. Barth, A. Quentmeier, and P. Moller. 1994. Differential expression of β1 integrins in nonneoplastic smooth and striated muscle cells and in tumors derived from these cells. Am. J. Pathol. 144: 1172-1182.
46. Mege, R.M., D. Goudou, C. Diaz, M. Nicolet, L. Garcia, G. Geraud, and F. Rieger. 1992. N-cadherin and N-CAM in myoblast fusion: compared localisation and effect of blockade by peptides and antibodies. J. Cell Sci. 103:897-906.
47. Mendrick, D.L., and D.M. Kelly. 1993. Temporal expression of VLA-2 and modulation of its ligand specificity by rat glomerular epithelial cells in vitro. Lab. Invest. 69:690-702.
48. Menko, A.S., and D. Boettiger. 1987. Occupation of the extracellular matrix receptor, integrin, is a control point for myogenic differentiation. Cell. 51:51-57.
49. Miyake, K., C.B. Underhill, J. Lesley, and P.W. Kincade. 1990. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med. 172:69-75.
50. Miyake, M., M. Koyama, M. Seno, and S. Ikeyama. 1991. Identification of the motilily-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J. Exp. Med. 174:1347-1354.
51. Nagira, M., T. Imai, I. Ishikawa, K.-I. Uwabe, and O. Yoshie. 1994. Mouse homologue of C33 antigen (CD82), a member of the transmembrane 4 superfamily: complementary DNA. genomic structure, and expression. Cell. Immunol. 157:144-157.
52. Nakamura, K., R. Iwamoto, and E. Mekada. 1995. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diptheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin α3β1 at cell-cell contact sites. J. Cell Biol. 129:1691-1705.
53. Okochi, H., M. Kato, K. Nashiro, O. Yoshie, K. Miyazono, and M. Furue. 1997. Expression of tetra-spans transmembrane family (CD9, CD37, CD53, CD63, CD81, CD82 and CD82) in normal and neoplastic human keratinocytes: an association of CD9 with alpha 3 beta 1 integrin. Br. J. Dermatol. 137:856-863.
54. Oritani, K., X. Wu, K. Medina, J. Hudson, K. Miyaki, J.M. Gimble, S.A. Burstein, and P.W. Kincade. 1996. Antibody ligation of CD9 modifies production of myeloid cells in long term cultures. Blood. 87:2252-2261.
55. Pileri, P., Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A.J. Weiner, M. Houghton, D. Rosa, G. Grandi, and S. Abrignani. 1998. Binding of hepatitis C virus to CD81. Science. 282:938-941.
56. Pujades, C., J. Teixidó, G. Bazzoni, and M.E. Hemler. 1996. Integrin cysteines 278 and 717 modulate VLA-4 ligand binding and also contribute to α4/180 formation. Biochem. J. 313:899-908.
57. Rapraeger, A.C., A. Krufka, and B.B. Olwin. 1991. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science. 252:1705-1708.
58. Rosen, G.D., J.R. Sanes, R. LaChance, J.M. Cunningham, J. Roman, and D.C. Dean. 1992. Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis. Cell. 69:1107-1119.
59. Sincock, P.M., G. Mayrohofer, and L.K. Ashman. 1997. Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: comparison with CD9, CD63, and α5β1 integrin. J. Histochem. Cytochem. 45:515-525.
60. Song, W.K., W. Wang, R.F. Forster, D.A. Bielser, and S.J. Kaufman. 1992. H36-α7 is a novel integrin alpha chain that is developmentally regulated during skeletal myogenesis. J. Cell Biol. 117:643-657.
61. Steffensen, B., V.L. Magnuson, C.L. Potempa, D. Chen, and R.J. Klebe. 1992. α5 integrin subunit expression changes during myogenesis. Biochim. Biophys. Acta. 1137:95-100.
62. Szollosi, J., V. Horejsi, L. Bene, P. Angelisova, and S. Damjanovich. 1996. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J. Immunol. 157:2939-2946.
63. Tai, X.G., Y. Yashiro, R. Abe, K. Toyo-oka, C.R. Wood, J. Morris, A. Long, S. Ono, M. Kobayashi, T. Hamaoka, et al. 1996. A role for CD9 molecules in T cell activation. J. Exp. Med. 184:753-758.
64. Tai, X.G., K. Toyo-oka, Y. Yashiro, R. Abe, C.S. Park, T. Hamaoka, M. Kobayashi, S. Neben, and H. Fujiwara. 1997. CD9-mediated costimulation of TCR-triggered naive T cells leads to activation followed by apoptosis. J. Immunol. 159:3799-3807.
65. Tanio, Y., H. Yamazaki, T. Kunisada, K. Miyake, and S.I. Hayashi. 1999. CD9 molecule expressed on stromal cells is involved in osteoclastogenesis. Exp. Hematol. 27:853-859.
66. Tapscott, S.J., M.J. Thayer, and H. Weintraub. 1993. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science. 259:1450-1453.
67. Taverna, D., M.-H. Disatnik, H. Rayburn, R.T. Bronson, J. Yang, T.A. Rando, and R.O. Hynes. 1998. Dystrophic muscle in mice chimeric for expression of α5 integrin. J Cell Biol. 143:849-859.
68. Todd, S.C., S.G. Lipps, L. Crisa, D.R. Salomon, and C.D. Tsoukas. 1996. CD81 expressed on human thymocytes mediates integrin activation and interleukin 2-dependent proliferation. J. Exp. Med 184:2055-2060.
69. Vachon, P.H., F. Loechel, H. Xu, U.M. Wewer, and E. Engvall. 1996. Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability. J. Cell Biol. 134:1483-1497.
70. Vachon, P.H., H. Xu, L. Liu, F. Loechel, Y. Hayashi, K. Arahata, J.C. Reed, U.M. Wewer, and E. Engvall. 1997. Integrins (α7β1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy. J. Clin. Invest. 100:1870-1881.
71. Walsh, K. 1997. Coordinate regulation of cell cycle and apoptosis during myogenesis. Prog. Cell Cycle Res. 3:53-58.
72. Weitzman, J.B., M.E. Hemler, and P. Brodt. 1996. Inhibition of rhabdomyosarcoma cell tumorigenicity by α3 integrin. Cell Adhes. Commun. 4:41-52.
73. Willett, B., M. Hosie, A. Shaw, and J. Neil. 1997. Inhibition of feline immunodeficiency virus infection by CD9 antibody operates after virus entry and is independent of virus tropism. J. Gen. Virol. 78:611-618.
74. Wright, M.D., and M.G. Tomlinson. 1994. The ins and outs of the transmembrane 4 superfamily. Immunol. Today. 15:588-594.
75. Yagami-Hiromasa, T., T. Sato, T. Kurisaki, K. Kamijo, Y. Nabeshima, and A. Fujisawa-Sehara. 1995. A metalloprotease-disintegrin participating in myoblast fusion. Nature. 377:652-656.
76. Yánez-Mó, M., A. Alfranca, C. Cabañas, M. Marazuela, R. Tejedor, M.A. Ursa, L.K. Ashman, M.O. De Landázuri, and F. Sánchez-Madrid. 1998. Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with α3β1 integrin localized at endothelial lateral junctions. J. Cell Biol. 141:791-804.
77. Yang, J.T., T.A. Rando, W.A. Mohler, H. Rayburn, H.M. Blau, and R.O. Hynes. 1996. Genetic analysis of α4 integrin functions in the development of mouse skeletal muscle. J Cell Biol. 135:829-835.
78. Yao, C.C., B.L. Ziober, A.E. Sutherland, D.L. Mendrick, and R.H. Kramer. 1996. Laminins promote the locomotion of skeletal myoblasts via the α7 integrin receptor. J. Cell Sci. 109:3139-3150.
79. Yauch, R.L., F. Berditchevski, M.B. Harler, J. Reichner, and M.E. Hemler. 1998. Highly stoichiometric, stable and specific association of integrin α3β1 with CD151 provides a major link to phosphatidylinositol 4-kinase and may regulate cell migration. Mol. Biol. Cell. 9:2751-2765.
80. Zeschnigk, M., D. Kozian, C. Kuch, M. Schmoll, and A. Starzinski-Powitz. 1995. Involvement of M-cadherin in terminal differentiation of skeletal muscle cells. J. Cell Sci. 108:2973-2981.